Clinical Trial Update: Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial is planned to evaluate adding liposomal transcrocetin to hypofractionated radiotherapy and temozolomide in newly diagnosed glioblastoma; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Liposomal transcrocetin (L-TC) (liposomal transcrocetin)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Institut de cancérologie Strasbourg Europe | Conditions: Glioblastoma | Phase 3 | Status: NOT_YET_RECRUITING